Breaking through lag: enhancing intradermal electro-osmotic flow and the future of delay-free continuous glucose monitoring

TL;DR

This study improves continuous glucose monitoring by reducing lag time through electro-osmotic flow, enhancing accuracy for diabetes management.

Contribution

A microfluidic device is developed to reduce lag time in glucose monitoring by enhancing electro-osmotic flow.

Findings

Lag time was reduced from 20 minutes to 5 minutes using electro-osmotic flow.

Enhanced convection improved glucose transport faster than diffusion alone.

The method shows potential for more accurate and timely glucose monitoring.

Abstract

Diabetes mellitus represents one of the most widespread chronic diseases globally, characterized by alterations in glucose metabolism that require constant monitoring of blood glucose levels. Traditionally, blood testing has been the standard for glucose monitoring; however, interstitial fluid has emerged as a viable alternative, due to its less invasive nature which enhances user comfort. Despite improvements in technology, the accuracy of currently available continuous glucose monitors remains a concern, particularly when the rate of change is higher, such as in hypoglycemic and hyperglycemic ranges. Effective management of hypoglycemia relies on the monitor’s ability to provide precise and specific readings when blood glucose levels drop dangerously low. In this context, the demand for heightened accuracy is paramount to timely alert users to impending hypoglycemic events. The inaccuracies of these sensors are attributed to the dynamics of the sample analysis. Specifically the interstitial fluid experiences a delay in concentration due to the diffusion process from capillary blood to interstitial fluid. In this study, we developed a microfluidic device that simulates the diffusion dynamics from capillary glucose to interstitial fluid. We demonstrate the reduction of lag time diffusion from 20 min to 5 min by increasing dermal electro-osmotic flow, which generates convection that transports glucose faster than diffusion, thus resulting in lower lag times. These findings highlight the potential of inciting electro-osmotic flow for improving the responsiveness and accuracy of CGMs, ultimately enhancing diabetes management for users.

Figures